AGH Stock Overview
Manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Althea Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.038 |
| 52 Week High | AU$0.054 |
| 52 Week Low | AU$0.017 |
| Beta | 1.48 |
| 11 Month Change | 2.70% |
| 3 Month Change | 100.00% |
| 1 Year Change | 5.56% |
| 33 Year Change | -84.17% |
| 5 Year Change | -90.00% |
| Change since IPO | -93.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| AGH | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | -11.6% | -7.0% | 1.2% |
| 1Y | 5.6% | 34.9% | 19.7% |
Return vs Industry: AGH underperformed the Australian Pharmaceuticals industry which returned 32.3% over the past year.
Return vs Market: AGH underperformed the Australian Market which returned 18.4% over the past year.
Price Volatility
| AGH volatility | |
|---|---|
| AGH Average Weekly Movement | 12.8% |
| Pharmaceuticals Industry Average Movement | 11.8% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: AGH's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: AGH's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Josh Fegan | altheagroupholdings.com |
Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name.
Althea Group Holdings Limited Fundamentals Summary
| AGH fundamental statistics | |
|---|---|
| Market cap | AU$19.80m |
| Earnings (TTM) | -AU$32.06m |
| Revenue (TTM) | AU$30.37m |
0.7x
P/S Ratio-0.6x
P/E RatioIs AGH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AGH income statement (TTM) | |
|---|---|
| Revenue | AU$30.37m |
| Cost of Revenue | AU$11.94m |
| Gross Profit | AU$18.43m |
| Other Expenses | AU$50.49m |
| Earnings | -AU$32.06m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.063 |
| Gross Margin | 60.69% |
| Net Profit Margin | -105.57% |
| Debt/Equity Ratio | 309.6% |
How did AGH perform over the long term?
See historical performance and comparison